K. Autio

2.1k total citations
32 papers, 1.6k citations indexed

About

K. Autio is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, K. Autio has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 9 papers in Molecular Biology. Recurrent topics in K. Autio's work include Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). K. Autio is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). K. Autio collaborates with scholars based in Finland, Sweden and Norway. K. Autio's co-authors include Sakari Knuutila, Ying Zhu, Maija Tarkkanen, Wael El‐Rifai, Johanna Tapper, Samuli Hemmer, Marcelo L. Larramendy, Outi Monni, Maija Wolf and Veli-Matti Wasenius and has published in prestigious journals such as The American Journal of Human Genetics, American Journal Of Pathology and Annals of Oncology.

In The Last Decade

K. Autio

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Autio Finland	17	693	483	389	277	274	32	1.6k
Barbara Czepulkowski United Kingdom	19	556 0.8×	142 0.3×	315 0.8×	226 0.8×	241 0.9×	49	1.7k
Sheila N.J. Sait United States	20	510 0.7×	192 0.4×	181 0.5×	178 0.6×	334 1.2×	72	1.2k
Markus Heidenblad Sweden	14	1.1k 1.5×	655 1.4×	316 0.8×	118 0.4×	332 1.2×	19	1.7k
Meena Kanduri Sweden	24	1.1k 1.6×	293 0.6×	405 1.0×	223 0.8×	162 0.6×	45	1.5k
F Viguié France	21	861 1.2×	206 0.4×	131 0.3×	136 0.5×	302 1.1×	45	1.6k
Nathalie Douet‐Guilbert France	23	703 1.0×	124 0.3×	629 1.6×	147 0.5×	122 0.4×	109	1.8k
S A Cannistra United States	11	816 1.2×	402 0.8×	181 0.5×	150 0.5×	644 2.4×	11	2.4k
NZ Parsa United States	15	430 0.6×	247 0.5×	174 0.4×	623 2.2×	514 1.9×	19	1.3k
Zenon Gibas United States	26	754 1.1×	486 1.0×	305 0.8×	330 1.2×	341 1.2×	55	1.9k
Preben Philip Denmark	25	978 1.4×	231 0.5×	256 0.7×	404 1.5×	474 1.7×	69	2.8k

Countries citing papers authored by K. Autio

Since Specialization

Citations

This map shows the geographic impact of K. Autio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Autio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Autio more than expected).

Fields of papers citing papers by K. Autio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Autio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Autio. The network helps show where K. Autio may publish in the future.

Co-authorship network of co-authors of K. Autio

This figure shows the co-authorship network connecting the top 25 collaborators of K. Autio. A scholar is included among the top collaborators of K. Autio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Autio. K. Autio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lang, Joshua M., Susan F. Slovin, Jamie M. Sperger, et al.. (2024). 1648P Final clinical and liquid biopsy (LBx) results of phase II trial of sacituzumab govitecan (SG) in patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) progressing on androgen receptor signaling inhibitors (ARSI). Annals of Oncology. 35. S993–S994. 1 indexed citations

Lundin, Catarina, Erik Forestier, Mette Klarskov Andersen, et al.. (2014). Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries. Journal of Hematology & Oncology. 7(1). 32–32. 10 indexed citations

Paulsson, Kajsa, Erik Forestier, Mette Klarskov Andersen, et al.. (2013). High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols. Haematologica. 98(9). 1424–1432. 35 indexed citations

Andersen, Mette Klarskov, K. Autio, Gisela Barbany, et al.. (2011). Paediatric B‐cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols. British Journal of Haematology. 155(2). 235–243. 24 indexed citations

Karrman, Kristina, Erik Forestier, Mats Heyman, et al.. (2009). Clinical and cytogenetic features of a population‐based consecutive series of 285 pediatric T‐cell acute lymphoblastic leukemias: Rare T‐cell receptor gene rearrangements are associated with poor outcome. Genes Chromosomes and Cancer. 48(9). 795–805. 22 indexed citations

Forestier, Erik, Mats Heyman, Mette K. Andersen, et al.. (2008). Outcome of ETV6/RUNX1‐positive childhood acute lymphoblastic leukaemia in the NOPHO‐ALL‐1992 protocol: frequent late relapses but good overall survival. British Journal of Haematology. 140(6). 665–672. 60 indexed citations

Autio, K. & Jim Schröder. (2008). Chromosome break points in clonal and nonclonal chromosome changes in human chronic lymphocytic leukemia. Hereditas. 97(2). 221–225.

Forestier, Erik, Mette K. Andersen, K. Autio, et al.. (2007). Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)‐positive B‐cell precursor acute lymphoblastic leukemias: A nordic series of 24 cases and review of the literature. Genes Chromosomes and Cancer. 47(2). 149–158. 22 indexed citations

Forestier, Erik, Mette K. Andersen, K. Autio, et al.. (2007). Cytogenetic patterns in ETV6/RUNX1‐positive pediatric B‐cell precursor acute lymphoblastic leukemia: A Nordic series of 245 cases and review of the literature. Genes Chromosomes and Cancer. 46(5). 440–450. 28 indexed citations

10.

Karrman, Kristina, Erik Forestier, Mette K. Andersen, et al.. (2006). High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B‐cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989–2005. British Journal of Haematology. 135(3). 352–354. 8 indexed citations

11.

Kanerva, Jukka, Kim Vettenranta, K. Autio, Sakari Knuutila, & Ulla M. Saarinen‐Pihkala. (2002). Minimal residual disease by metaphase FISH in children with ALL: clonal cells during or after chemotherapy may not predict relapse. Leukemia Research. 26(6). 545–550. 1 indexed citations

12.

Vettenranta, Kim, K. Autio, Liisa Hovi, Sakari Knuutila, & U M Saarinen-Pihkala. (2002). Follow-up of Minimal Residual Disease in Pediatric Acute Myeloblastic Leukemia Using Metaphase-FISH. Leukemia & lymphoma. 43(6). 1261–1265. 2 indexed citations

13.

Knuutila, Sakari, Yan Aalto, K. Autio, et al.. (1999). DNA Copy Number Losses in Human Neoplasms. American Journal Of Pathology. 155(3). 683–694. 332 indexed citations

14.

Vlachodimitropoulos, Dimitrios, Hannu Norppa, K. Autio, et al.. (1997). GSTT1-dependent induction of centromere-negative and -positive micronuclei by l,2:3,4-diepoxybutane in cultured human lymphocytes. Mutagenesis. 12(5). 397–403. 55 indexed citations

15.

Catalán, Julia, K. Autio, Maija Wessman, et al.. (1995). Age-associated micronuclei containing centromeres and the X chromosome in lymphocytes of women. Cytogenetic and Genome Research. 68(1-2). 11–16. 70 indexed citations

16.

Sorsa, Marja, K. Autio, N.A. Demopoulos, et al.. (1994). Human cytogenetic biomonitoring of occupational exposure to 1,3-butadiene. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 309(2). 321–326. 52 indexed citations

17.

Autio, K., et al.. (1994). Induction of micronuclei in peripheral blood and bone marrow erythrocytes of rats and mice exposed to 1,3-butadiene by inhalation. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 309(2). 315–320. 47 indexed citations

18.

Sorsa, Marja, K. Autio, E. Carbonell, et al.. (1992). Evaluation of in vitro cytogenetic techniques in nine European laboratories in relation to chromosomal endpoints induced by three model mutagens. Mutation Research/Environmental Mutagenesis and Related Subjects. 271(3). 261–267. 11 indexed citations

19.

Autio, K., Erkki Elonen, L. Teerenhovi, & Sakari Knuutila. (1987). Cytogenetic and immunologic characterization of mitotic cells in chronic lymphocytic leukaemia. European Journal Of Haematology. 39(4). 289–298. 48 indexed citations

20.

Autio, K., et al.. (1979). Human Chronic Lymphocytic Leukaemia Surface Markers and Activation of Lymphocytes. Scandinavian Journal of Haematology. 23(4). 265–271. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact